15 employees
Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.
2013
$16M
from 2 investors over 2 rounds
TREOS BIO Zrt raised $16M on March 31, 2021
Investors: Luminous Ventures
TREOS BIO Zrt raised $14M on March 20, 2021